ClinicalPK-steady state concentration
and half -life
Dr Kalpana Tiwari
Learning objectives-
 To explain concept
 Measurement and significance of kinetics of drug
elimination
 Measurement and significance of half life
 Measurement and significance of steady state conc
Clinical Pharmacokinetics….
Relation between concentration of the drug & its pharmacological
effects, as these change in time
Pharmacological effects :Desired /adverse effect
To know Quantitative relationship between dose &
effect
Adjust drug concentration in biological fluids through
changes in dosing
clinical
pharmacokinetics
Bioavailability, Volume of distribution,
Clearance, Elimination t1/2
Important
parameters
Linear/non-linear pharmacokinetics
 Doses are increased for most drugs steady-state
concentrations increase in a proportional fashion
leading to linear pharmacokinetics
 When steady-state concentrations change in a
disproportionate fashion after the dose is altered
nonlinear pharmacokinetics
Pharmacokinetics models
Compartmental model
Compartmental models are categorized by number of
compartments needed to describe drug's behavior in body
 One- compartment, Two-compartment and
Multicompartment models
 Compartments do not represent a specific tissue or fluid
but may represent a group of similar tissues or fluids
 Models can be used to predict time course of drug
concentrations in body
one compartment model
• Drug is evenly distributed throughout the body into a single
compartment
• This model is only appropriate for drugs which rapidly and
readily distribute between the plasma and other body
tissues
Two compartment model.
•Drugs which exhibit a slow equilibration with
peripheral tissues, are best described
 Solid line shows serum concentration/time graph for drug
that follows one-compartment model PK
 Dashed line represents serum concentration/time plot
for drug that follows two- compartment model PK after
intravenous bolus is given
Importance of two-compartment models
 For many drugs multicompartment kinetics may be
observed for significant periods of time
 Failure to consider distribution phase can lead to
significant errors in estimates of clearance and in
predictions of appropriate dosage
 Also difference between "central" distribution volume is
important in deciding a loading dose strategy
Half life
• Amount of time over which drug conc.in plasma decrease to
one half of its original value
t1/2=0.693Vd/ Clearance
Plasma half life (t1/2)
• Generally it is measured by –
• The time to decline plasma concentration of a drug Plasma half life
(t1/2) of drug
• Time to decline conc. from 100 to 50 = 2 hr t1/2 of this drug is 2 hr
Plasma half life (t1/2) of drug
 Generally a drug will be completely eliminated
after 6 half lives-
 After 1 half-life the conc. will be 50%
 After 2 half-lives it will be 25%
After 3 half-lives 12.5% and
 After 4 half-lives 6.25%
 After 5 half-lives 3.125%
After 6 half-lives 1.56%
Why is half-life important ?
Half-life is a major determinant of
 Duration of action after a single dose
 Time required to reach steady state
 Dosing frequency
 Importance of( t 1/2 A)
 Estimation of dosing schedule
It defines time interval between doses, and is very
important in design of infusion systems
Estimation of time to drug elimination
It gives idea to estimate time to total drug elimination
Generally most drugs will be eliminated in approximately
six half-lives
Kinetics of drug elimination
Rate and pattern of drug elimination follow
First order
Zero order
Mixed Order Kinetics
First order kinetics
 Majority of the drugs follow this type of elimination
A constant fraction of the drug is eliminated at a constant
interval of time. eg: Plasma concentration declining at a rate
of 50% per two hours
 100 µg/ ml 50 µg/ml
25 µg/ ml
12.5 µg/ml and so on
First order kinetics: (contd.)
 Rate of drug elimination is directly proportional to the
plasma concentration eg: 200-> 100-> 50-> 25-> 12.5
so on
 t ½ of any drug would always remain constant
irrespective of the dose
First order kinetics: (contd.)
 Plasma concentration is plotted against time , the resultant
“ plasma fall-out curve” curvilinear
 Log of plasma concentration are plotted against time
resultant curve - linear
Zero order kinetics
 A constant or a fixed quantity of drug is eliminated per unit
time rate of elimination is independent of the concentration
of drug in plasma
 Ethyl alcohol exhibit zero order at virtually all plasma
concentrations
 For eg: if plasma concentration falls at a rate of 25 µg per
hour then 50mg
25mg
nil
t ½ of a drug following zero order is never constant
Zero order kinetics
If such a fall in plasma concentration is plotted against
time the resultant “plasma fall-out curve” is steeply linear
 if logarithm of plasma concentration are plotted against
time then the curve becomes curvilinear
Mixed Order Kinetics/ Saturation Kinetics
 Dose-dependent kinetics - smaller doses are eliminated by
first order kinetics as plasma concentration reaches higher
values rate of drug elimination- zero order
 Phenytoin, warfarin After a single dose administration if
plasma concentrations are plotted against time resultant
curve remains linear in beginning (zero order) and then
become predominantly exponential ( curvilinear i.e. first
order)
Clinical Importance:
 Drugs having very short half-life are given by constant i.v.
infusion to maintain steady state concentration
 For drugs having longer t ½, with high Vd & slow rate of
clearance also are cumulative in nature
To reach steady state Loading dose given Maintenance
dose
Loading dose= Desired plasma conc. x aVd
Clinical Importance:
Digoxin 0.25 mg given/24 hour 5 days a week considering
its nature of accumulation
 Lignocaine in cardiac arrhythmia- loading dose given
irrespective of shorter t ½
 Loading dose also necessary in case of certain antibiotics
to keep the plasma conc. higher than MIC
Fixed-Dose Drug Combination
 Rationale fixed-drug formulation of two drugs can be
advantageous drug should have equal t ½ Eg Cotrimoxazole
(Sulfamethoxazole [t ½ 11 hr]) & Trimethoprim [t ½ 10 hr]
Ratio of dose depends on aVd & plasma conc. Of individual
drug eg t ½ & Vd of Amoxycillin (1-2hr 0.21 L/kg) matches
with t ½ &Vd of Clavulanic acid (1-1.5hr 0.20 L/kg )
Advantage of Fixed-dose formulation
 Convenient dose schedule
 Better patient compliance
 Enhanced effect
 Minimal side effect
Steady State
Amount of drug administered is equal to amount of drug
eliminated within one dosing interval resulting in a plateau
or constant serum drug level
 Drugs with short half-life reach steady state rapidly
 Drugs with long half-life take days to weeks to reach
steady state
Drug bioavailability, clearance, dose, and
Dosing interval (the frequency of administration)
Why is it important ?
 Rate in = Rate Out
 Reached in 4 – 5 half-lives (linear kinetics)
Steady State
Applied Steady State
 Effective pharmacological management of diseases
 Serum concentrations of antibiotics need to remain within a
clinically effective range for optimal treatment
Concentrations below range could fail to treat infections and
levels above range could cause toxicity
 General anesthesia in totally intravenous anesthesia (TIVA)
of propofol and remifentanil are used to maintain a constant
blood concentration and therefore a predictable
concentration at site effector (brain)
Applied Steady State
 longer half life high Vd and slow rate of clearance (Digoxin
40 hr),chloroquine (40hr 130L) need 5 half life to reach SSC
leads several days to achieve therapeutic range
 If there is clinical emergency like CHF cause fatal for patient
in such case loading dose is required followed by MD to
achieve steady state
Drug very short half life (dopamine epinephrine) usually
given by a constant IV infusion to maintain steady state PC
References
•PRINCIPLES of PHARMACOLOGY THE
PATHOPHYSIOLOGIC BASIS OF DRUG
THERAPY third edition by GOLAN
•13th edition 2018 Goodman & Gilman
•Rang and Dale 8th

Half life ppt

  • 1.
    ClinicalPK-steady state concentration andhalf -life Dr Kalpana Tiwari
  • 2.
    Learning objectives-  Toexplain concept  Measurement and significance of kinetics of drug elimination  Measurement and significance of half life  Measurement and significance of steady state conc
  • 3.
    Clinical Pharmacokinetics…. Relation betweenconcentration of the drug & its pharmacological effects, as these change in time Pharmacological effects :Desired /adverse effect To know Quantitative relationship between dose & effect Adjust drug concentration in biological fluids through changes in dosing clinical pharmacokinetics Bioavailability, Volume of distribution, Clearance, Elimination t1/2 Important parameters
  • 4.
    Linear/non-linear pharmacokinetics  Dosesare increased for most drugs steady-state concentrations increase in a proportional fashion leading to linear pharmacokinetics  When steady-state concentrations change in a disproportionate fashion after the dose is altered nonlinear pharmacokinetics
  • 5.
    Pharmacokinetics models Compartmental model Compartmentalmodels are categorized by number of compartments needed to describe drug's behavior in body  One- compartment, Two-compartment and Multicompartment models  Compartments do not represent a specific tissue or fluid but may represent a group of similar tissues or fluids  Models can be used to predict time course of drug concentrations in body
  • 6.
    one compartment model •Drug is evenly distributed throughout the body into a single compartment • This model is only appropriate for drugs which rapidly and readily distribute between the plasma and other body tissues
  • 7.
    Two compartment model. •Drugswhich exhibit a slow equilibration with peripheral tissues, are best described
  • 8.
     Solid lineshows serum concentration/time graph for drug that follows one-compartment model PK  Dashed line represents serum concentration/time plot for drug that follows two- compartment model PK after intravenous bolus is given
  • 9.
    Importance of two-compartmentmodels  For many drugs multicompartment kinetics may be observed for significant periods of time  Failure to consider distribution phase can lead to significant errors in estimates of clearance and in predictions of appropriate dosage  Also difference between "central" distribution volume is important in deciding a loading dose strategy
  • 10.
    Half life • Amountof time over which drug conc.in plasma decrease to one half of its original value t1/2=0.693Vd/ Clearance
  • 11.
    Plasma half life(t1/2) • Generally it is measured by – • The time to decline plasma concentration of a drug Plasma half life (t1/2) of drug • Time to decline conc. from 100 to 50 = 2 hr t1/2 of this drug is 2 hr
  • 13.
    Plasma half life(t1/2) of drug  Generally a drug will be completely eliminated after 6 half lives-  After 1 half-life the conc. will be 50%  After 2 half-lives it will be 25% After 3 half-lives 12.5% and  After 4 half-lives 6.25%  After 5 half-lives 3.125% After 6 half-lives 1.56%
  • 14.
    Why is half-lifeimportant ? Half-life is a major determinant of  Duration of action after a single dose  Time required to reach steady state  Dosing frequency  Importance of( t 1/2 A)  Estimation of dosing schedule It defines time interval between doses, and is very important in design of infusion systems Estimation of time to drug elimination It gives idea to estimate time to total drug elimination Generally most drugs will be eliminated in approximately six half-lives
  • 15.
    Kinetics of drugelimination Rate and pattern of drug elimination follow First order Zero order Mixed Order Kinetics
  • 16.
    First order kinetics Majority of the drugs follow this type of elimination A constant fraction of the drug is eliminated at a constant interval of time. eg: Plasma concentration declining at a rate of 50% per two hours  100 µg/ ml 50 µg/ml 25 µg/ ml 12.5 µg/ml and so on
  • 17.
    First order kinetics:(contd.)  Rate of drug elimination is directly proportional to the plasma concentration eg: 200-> 100-> 50-> 25-> 12.5 so on  t ½ of any drug would always remain constant irrespective of the dose
  • 18.
    First order kinetics:(contd.)  Plasma concentration is plotted against time , the resultant “ plasma fall-out curve” curvilinear  Log of plasma concentration are plotted against time resultant curve - linear
  • 19.
    Zero order kinetics A constant or a fixed quantity of drug is eliminated per unit time rate of elimination is independent of the concentration of drug in plasma  Ethyl alcohol exhibit zero order at virtually all plasma concentrations  For eg: if plasma concentration falls at a rate of 25 µg per hour then 50mg 25mg nil t ½ of a drug following zero order is never constant
  • 20.
    Zero order kinetics Ifsuch a fall in plasma concentration is plotted against time the resultant “plasma fall-out curve” is steeply linear  if logarithm of plasma concentration are plotted against time then the curve becomes curvilinear
  • 22.
    Mixed Order Kinetics/Saturation Kinetics  Dose-dependent kinetics - smaller doses are eliminated by first order kinetics as plasma concentration reaches higher values rate of drug elimination- zero order  Phenytoin, warfarin After a single dose administration if plasma concentrations are plotted against time resultant curve remains linear in beginning (zero order) and then become predominantly exponential ( curvilinear i.e. first order)
  • 24.
    Clinical Importance:  Drugshaving very short half-life are given by constant i.v. infusion to maintain steady state concentration  For drugs having longer t ½, with high Vd & slow rate of clearance also are cumulative in nature To reach steady state Loading dose given Maintenance dose Loading dose= Desired plasma conc. x aVd
  • 25.
    Clinical Importance: Digoxin 0.25mg given/24 hour 5 days a week considering its nature of accumulation  Lignocaine in cardiac arrhythmia- loading dose given irrespective of shorter t ½  Loading dose also necessary in case of certain antibiotics to keep the plasma conc. higher than MIC
  • 26.
    Fixed-Dose Drug Combination Rationale fixed-drug formulation of two drugs can be advantageous drug should have equal t ½ Eg Cotrimoxazole (Sulfamethoxazole [t ½ 11 hr]) & Trimethoprim [t ½ 10 hr] Ratio of dose depends on aVd & plasma conc. Of individual drug eg t ½ & Vd of Amoxycillin (1-2hr 0.21 L/kg) matches with t ½ &Vd of Clavulanic acid (1-1.5hr 0.20 L/kg ) Advantage of Fixed-dose formulation  Convenient dose schedule  Better patient compliance  Enhanced effect  Minimal side effect
  • 27.
    Steady State Amount ofdrug administered is equal to amount of drug eliminated within one dosing interval resulting in a plateau or constant serum drug level  Drugs with short half-life reach steady state rapidly  Drugs with long half-life take days to weeks to reach steady state Drug bioavailability, clearance, dose, and Dosing interval (the frequency of administration) Why is it important ?  Rate in = Rate Out  Reached in 4 – 5 half-lives (linear kinetics)
  • 28.
  • 29.
    Applied Steady State Effective pharmacological management of diseases  Serum concentrations of antibiotics need to remain within a clinically effective range for optimal treatment Concentrations below range could fail to treat infections and levels above range could cause toxicity  General anesthesia in totally intravenous anesthesia (TIVA) of propofol and remifentanil are used to maintain a constant blood concentration and therefore a predictable concentration at site effector (brain)
  • 30.
    Applied Steady State longer half life high Vd and slow rate of clearance (Digoxin 40 hr),chloroquine (40hr 130L) need 5 half life to reach SSC leads several days to achieve therapeutic range  If there is clinical emergency like CHF cause fatal for patient in such case loading dose is required followed by MD to achieve steady state Drug very short half life (dopamine epinephrine) usually given by a constant IV infusion to maintain steady state PC
  • 34.
    References •PRINCIPLES of PHARMACOLOGYTHE PATHOPHYSIOLOGIC BASIS OF DRUG THERAPY third edition by GOLAN •13th edition 2018 Goodman & Gilman •Rang and Dale 8th